- Investing.com
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Digital Health Pionee | OptimizeRx leads in digital health messaging, leveraging AI and strategic acquisitions to revolutionize pharmaceutical marketing in a rapidly evolving healthcare landscape. |
Financial Crossroads | Despite recent revenue challenges, OptimizeRx maintains strong growth metrics and healthy margins, with analysts projecting price targets ranging from $6 to $16. |
DAAP: Growth Engine | Explore the potential of OptimizeRx's Digital Advertising Awareness Platform, offering higher margins and larger deal sizes, with significant upsell opportunities among existing clients. |
Navigating Headwinds | Delve into OptimizeRx's strategies for overcoming contract delays, policy uncertainties, and competitive pressures while capitalizing on the shift to digital pharma marketing. |
Metrics to compare | OPRX | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipOPRXPeersSector | |
---|---|---|---|---|
P/E Ratio | −32.5x | −1.1x | −0.5x | |
PEG Ratio | −0.69 | 0.02 | 0.00 | |
Price/Book | 2.7x | 1.2x | 2.6x | |
Price / LTM Sales | 3.1x | 1.5x | 3.3x | |
Upside (Analyst Target) | −7.5% | 30.5% | 43.4% | |
Fair Value Upside | Unlock | 42.2% | 7.1% | Unlock |